REST  ·  RISE  ·  RENEW Close the loop.  ·  Shop the System
Longevity4 min read · January 2026

NMN vs NAD+: Which Supplement Is Right for You?

NMN and NAD+ target the same cellular decline but work differently. Here's the science, the evidence and how to choose between them.

NMN vs NAD+: Which Supplement Is Right for You?
Reviewed by: AE·ORA Editorial TeamLast reviewed: August 20, 2026Evidence basis: Peer-reviewed research, PubMed-cited. Human, animal and yeast studies labelled separately.

Short answer: they are not competitors. NAD+ is the coenzyme your cells actually use; NMN is a precursor one enzymatic step away from it. Supplements overwhelmingly use precursors because NAD+ itself is a large, unstable molecule. The human trial evidence sits with the precursors.

How NAD+ biosynthesis works

Cells cannot make NAD+ from nothing; they build and recycle it through enzymatic pathways. NMN sits one step away — the NMNAT enzyme converts NMN to NAD+ directly. NAD+ taken orally faces a longer route, being substantially broken down before its components are reassembled inside cells.

That difference is mechanistic reasoning rather than a head-to-head trial result, and it should be read as such. Background in How NAD+ Precursors Actually Work.

The human NMN evidence

Yoshino and colleagues (2021) in Science gave 250 mg NMN daily for 10 weeks to 25 postmenopausal women with prediabetes, and reported improved muscle insulin sensitivity. Note the population: prediabetic, not healthy. This page previously described them as healthy older women and credited the trial with walking-speed improvements it did not report; both have been corrected.

Two further human trials: Liao and colleagues (2021) found improved aerobic capacity in amateur runners over six weeks, and Igarashi and colleagues (2022) found raised blood NAD+ and altered muscle function in healthy older men. Full detail in NMN Supplement Benefits.

The CD38 question and quercetin

CD38 is an enzyme that consumes NAD+, and its activity rises with age and inflammation — so NAD+ balance is a function of both supply and degradation.

Camacho-Pereira and colleagues (2016) in Cell Metabolism showed CD38 dictates age-related NAD+ decline and mitochondrial dysfunction through a SIRT3-dependent mechanism, using CD38-knockout mice.

Quercetin inhibits CD38, which is the rationale for including it at 250 mg in the NAD+ Full Stack. Two honest caveats: the CD38 work is in mice, and there is no human trial showing that quercetin raises NAD+ in people. It is a mechanistic rationale, not a demonstrated outcome. An earlier version of this page cited a review about mTOR for the CD38 finding — a wrong citation, now corrected.

Resveratrol and the sirtuins

Sirtuins are NAD+-dependent enzymes involved in cellular repair and metabolic regulation — they cannot function without NAD+, which is the coherent part of the pairing rationale.

Resveratrol entered this story through Howitz and colleagues (2003) in Nature, which identified small-molecule sirtuin activators and reported lifespan extension — in yeast. Whether resveratrol activates SIRT1 directly in humans has been contested in the years since, and we are not going to present it as settled. We previously cited a paper on folate transport for this claim, which was simply wrong.

What can fairly be said: sirtuins require NAD+, resveratrol is studied alongside NAD+ precursors, and combining them is mechanistically rational. That is not the same as proof the combination outperforms a precursor alone in people.

How to choose

If you want the simplest, best-evidenced entry point, that is a precursor: NMN at 500 mg. If you want the pathway approach — supply plus retention plus downstream activation — the NAD+ Full Stack pairs 500 mg β-NAD+ with quercetin and 98% trans-resveratrol, and the Longevity Stack combines both.

Taking them together is reasonable and there is no known interaction. Just hold the expectation at the right level: this is a mechanistically coherent stack with early human data behind its central ingredient, not a proven longevity intervention.

Frequently Asked Questions

Quick answers to the questions readers most often ask.

What is the difference between NMN and NAD+?

NAD+ is the coenzyme cells actually use. NMN is a precursor one enzymatic step away, converted by NMNAT. Oral NAD+ is substantially broken down before reassembly inside cells, which is why supplements generally use precursors and why the human trial evidence sits with precursors.

Is NMN or NAD+ better for energy?

Both aim at the same endpoint: more NAD+ available for mitochondrial ATP production. NMN is the more direct route mechanistically and has the human trial data. Neither produces an acute felt effect; this is a weeks-to-months intervention, not a stimulant.

Can you take NMN and NAD+ together?

Yes, and there is no known interaction. They enter the same pathway at different points. Note this is a mechanistic rationale rather than a combination proven superior to a precursor alone in human trials.

What is 99.9% purity beta-NMN?

NMN exists as a biologically active beta anomer and an inactive alpha form, and only beta-NMN is efficiently converted by the NMNAT enzyme. A 99.9% purity specification means essentially all of the stated dose is the active isomer rather than inactive material or manufacturing byproduct.

How does quercetin help with NAD+ levels?

Quercetin inhibits CD38, an enzyme that consumes NAD+ and whose activity increases with age and inflammation. The CD38 evidence comes from knockout-mouse work, and there is no human trial showing quercetin raises NAD+ in people, so treat it as a mechanistic rationale rather than a demonstrated outcome.


These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Shop this formula

Magnesium Glycinate, 275mg elemental

Pure bisglycinate chelate. 90 capsules, a full 30-night supply at the research dose. Subscribe and save 15%.